Related Experiment Video
Updated: Jan 5, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
New Approaches on Cancer Immunotherapy
Jong-Ho Cha1,2, Li-Chuan Chan1,3, Min Sup Song1
1Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer metastasis is a leading cause of death. Immunotherapy shows promise in preventing cancer spread and recurrence by leveraging immune cells to target metastatic processes.
Area of Science:
- Oncology
- Immunology
Background:
- Metastasis, the spread of cancer cells, is the primary cause of cancer-related mortality.
- Recurrent metastatic tumors present a significant challenge in cancer treatment and elimination.
- Immunotherapy has shown potential in improving survival rates and reducing metastatic relapse.
Purpose of the Study:
- To summarize immunological events involved in tumor progression and metastasis.
- To discuss immunotherapies that can target cancer metastasis.
Main Methods:
- Review of clinical studies on immunotherapy and metastasis.
- Analysis of the role of host immune cells in tumor microenvironment and metastasis.
- Synthesis of information on immunological events in cancer progression.
Main Results:
- Immunotherapy responders exhibit improved survival and reduced metastatic relapse.
- Host immune cells play a crucial role in shaping the tumor microenvironment and metastasis.
- Understanding immunological events is critical for improving clinical outcomes.
Conclusions:
- Immunotherapy represents a potential strategy to combat cancer metastasis.
- Targeting immunological events in metastasis can improve patient outcomes.
- Further research into immunotherapy for metastatic cancer is warranted.
More Related Videos
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...